PATH Request for Partnership: Clinical evaluation of novel malaria RDTs among asymptomatic populations
PATH is seeking for Partnership for a clinical study to evaluate the performance of novel malaria rapid diagnostic tests (RDTs) among asymptomatic populations. PATH is looking for organizations that have experience in implementing malaria clinical research, and demonstrated capacity to execute a malaria diagnostic performance evaluation.
Organizations based in the following countries are encouraged to apply: Democratic Republic of the Congo, Djibouti, Eritrea, Ethiopia, Malawi, Mozambique, Uganda, Tanzania, and Zambia.
If your organization is interested in this opportunity, please submit any questions we can answer by 25 October 2024.Â
Important dates:Â
- Questions submission deadline – October 25, 2024
- PATH to respond deadline – November 1, 2024
- Partnership application deadline – December 2, 2024 (17:00 GMT)
Read more here.
